MedTrace Logo

The Impact of ResuGlove as a Chest Compression Feedback Device

NCT05695469 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2023-09-15

No results posted yet for this study

Summary

The goal of this simulation-based randomized trial is to assess if the newly proposed ResuGlove can improve the quality of chest compressions during CPR training of laypersons and inexperienced health professionals. The main questions it aims to answer are:

1. To determine if the newly developed wearable resuscitation gloves will improve the quality of chest compression during simulation-based CPR training
2. To determine the learnability and usability of the ResuGlove using the System Usability Scale (SUS) questionnaire

Participants will be randomly assigned into two equal groups the ResuGlove group (group 1) vs the traditional CPR group (Group 2). The investigators will compare the quality of chest compression between these two groups. On the same day, participants will be asked about the learnability and usability of ResuGlove using the System Usability Scale (SUS questionnaire.

Conditions

  • Testing, Reality

Interventions

DEVICE

Smart resuscitation glove (ResuGlove)

Participants will be randomly assigned into two equal groups using the online-based random number generator (https://www.random.org). Participants in the ResuGlove group will perform hand-only CPR wearing the ResuGlove with a running feedback program for 2 minutes.

OTHER

Traditional CPR

Participants in the traditional CPR group will perform hand-only CPR without the ResuGlove and feedback guidance for 2 minutes.

Sponsors & Collaborators

  • Aalto University

    collaborator OTHER

  • University of Turku

    lead OTHER

Principal Investigators

  • Desale T Kahsay, MSc · University of Turku

  • Sanna Salanterä, Professor · University of Turku

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-23
Primary Completion
2023-09-14
Completion
2023-09-14

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05695469 on ClinicalTrials.gov